Ludwig Burger

@MikeBenzCyber @Hillsdale The

"The History of the Intelligence State" -- an essential 40 min lecture on the origin story of The Blob. Thanks to @Hillsdale for a beautiful event. Timestamps in tweet below

The chemical industry’s path toward sustainability was never going to linear. @UmicoreGroup #EVs chemicalesg.com/ev-cathodes-we…

It's early days for the science underpinning any use of #cgm in endurance sports. More to geek out on here: #continuousglucosemonitoring #glucose reuters.com/sports/olympic…

Medical diagnostic tech is making the leap to elite sports. With @Sripootweets #cgm #continuousglucosemonitoring #glucose reuters.com/sports/olympic…

It would be a cash call for all the wrong reasons, but some sell-side and buy-side analysts are giving serious thought to that scenario at embattled #Bayer. With @EmmaVictoriaF and Patricia Weiss tinyurl.com/yt2eczx4

This is a great story - not because of any narrative but because of what happened. reuters.com/business/healt…

New #Bayer CEO Bill Anderson is walking the talk about too much red tape at the German healthcare and agriculture company. But that should only be a step on the way to bigger changes. reuters.com/business/bayer…

Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy, a source familiar with the matter told Reuters. reut.rs/3YLoDmZ

In the words of Emily Field and team @BarclaysCIB "If they play baseball in Denmark, #Wegovy just hit a home run" reuters.com/business/healt…

A debate to follow when #Wegovy comes to market in Germany this month: Will there be, at some point, any change in drug coverage policies that some say reflects a stigmatisation of obesity? reuters.com/business/healt…

#NovoNordisk's #Wegovy is coming to self-payer market Germany for a little over €300 per month. Overwhelmed by demand elsewhere, the company is already pleading for restraint with German doctors. reuters.com/business/healt…

German hidden champion Freiberger Compound Materials consumes about 10% of the global #gallium production. It is for now relatively relaxed about Chinese export controls but its clients clearly are not. reuters.com/markets/commod…

Europe's public-health policy makers are largely immune to the hype over new #obesity drugs. Case in point: Germany is developing a disease management programme for obesity but a no-reimbursement rule for weight-loss drugs will not be touched. reuters.com/business/healt…

Sanofi, one of the largest influenza vaccines suppliers, says the industry's current generation of mRNA flu vaccine candidates will not be up to the task. Will we hear Pfizer, BioNTech and Moderna say 'speak for yourself' ? reuters.com/business/healt…

#BlueRock, acquired by #Bayer in 2019, is making early progress on #parkinsons #parkinsonsdisease stem cell therapy development. A crowded field of research teams around the globe is pursuing this complex technology. reuters.com/business/healt…

Seems about right smbc-comics.com/comic/gifted

I personally don't mind if pharmaceutical companies make a lot of money out of those drugs if they delivered. For Big Pharma haters, there's still the consolation that there would be far less money to be made out of diabetes type 2, hypertension, statins and whatnot drugs. 2/

"Investors love simple structures, with a clear focus on the core business. This is the case everywhere, not only in Germany," @JoeKaeser tells us. He should know. @Siemens_Energy @Siemens @LudwigBurger reuters.com/business/germa…

The UK's recent disastrous "mini" Budget can trace its origins back to Britain's decision to leave the European Union. The economic costs of Brexit were masked by the pandemic and the Ukraine crisis. But six years after the vote, the Brexit effect is clear youtu.be/wO2lWmgEK1Y